NITROLINGUAL

This brand name is authorized in United States. It is also authorized in Australia, Austria, Croatia, Estonia, Germany, Hong Kong SAR China, Ireland, Israel, Lithuania, Malta, Netherlands, New Zealand, South Africa, Turkey, UK.

Active ingredients

The drug NITROLINGUAL contains one active pharmaceutical ingredient (API):

1	Glyceryl trinitrate UNII G59M7S0WS3 - NITROGLYCERIN
	Glyceryl trinitrate is a vasodilator and is used for angina of effort. Vasodilation is achieved by the releasing of free redical nitric oxide which activates guanylate cyclase and increases synthesis of guanosine 3′ and 5′-monophosphate with resultant effects on the phosphorylation of proteins in smooth muscle. If taken in excess, its vasodilatory effect can cause headache.
	Read more about Glyceryl trinitrate

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
NITROLINGUAL Sublingual spray	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
C01DA02	Glyceryl trinitrate	C Cardiovascular system → C01 Cardiac therapy → C01D Vasodilators used in cardiac diseases → C01DA Organic nitrates
Discover more medicines within C01DA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	3475X, 8171C
CA	Health Products and Food Branch	02231441
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	11084508, 15318854, 16357856, 16794479
EE	Ravimiamet	1152290, 1298606
GB	Medicines & Healthcare Products Regulatory Agency	183521, 183523, 183529, 183531, 220291, 240026, 381561
HK	Department of Health Drug Office	35453
HR	Agencija za lijekove i medicinske proizvode	HR-H-453122375
IE	Health Products Regulatory Authority	40664, 42433
IL	מִשְׂרַד הַבְּרִיאוּת	3413
LT	Valstybinė vaistų kontrolės tarnyba	1001386
MT	Medicines Authority	AA521/07003, AA565/42601, AA770/13701, AA908/09202
NL	Z-Index G-Standaard	14947641
NL	Z-Index G-Standaard, PRK	72214
NZ	Medicines and Medical Devices Safety Authority	3542
TR	İlaç ve Tıbbi Cihaz Kurumu	8699738520014
US	FDA, National Drug Code	28595-550
ZA	Health Products Regulatory Authority	P/7.1.4/281